ESI-MS studies on prolyl hydroxylase domain 2 reveal a new metal binding site.

ESI-MS studies on prolyl hydroxylase domain 2 reveal a new metal binding site.

Bibliographic Details
Main Authors:	Mecinović, J, Chowdhury, R, Liénard, B, Flashman, E, Buck, MR, Oldham, N, Schofield, C
Format:	Journal article
Language:	English
Published:	2008

Similar Items

BIOL 56-ESI-MS studies on prolyl hydroxylase domain 2
by: Mecinovic, J, et al.
Published: (2008)

Mass spectrometric studies on an oxygen sensing prolyl hydroxylase
by: Mecinovic, J, et al.
Published: (2007)

Use of mass spectrometry to probe the nucleophilicity of cysteinyl residues of prolyl hydroxylase domain 2.
by: Mecinović, J, et al.
Published: (2009)

2-Oxoglutarate analogue inhibitors of prolyl hydroxylase domain 2.
by: Mecinović, J, et al.
Published: (2009)

Structural basis for binding of hypoxia-inducible factor to the oxygen-sensing prolyl hydroxylases.
by: Chowdhury, R, et al.
Published: (2009)

2-oxoglutarate regulates binding of hydroxylated hypoxia-inducible factor to prolyl hydroxylase domain 2
by: Abboud, M, et al.
Published: (2018)

Studies on the reaction of nitric oxide with the hypoxia-inducible factor prolyl hydroxylase domain 2 (EGLN1)
by: Chowdhury, R, et al.
Published: (2011)

Studies on the reaction of nitric oxide with the hypoxia-inducible factor prolyl hydroxylase domain 2 (EGLN1).
by: Chowdhury, R, et al.
Published: (2011)

Investigating the contribution of the active site environment to the slow reaction of hypoxia-inducible factor prolyl hydroxylase domain 2 with oxygen.
by: Tarhonskaya, H, et al.
Published: (2014)

Structural basis of prolyl hydroxylase domain inhibition by Molidustat
by: Figg, WD, et al.
Published: (2021)

Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents.
by: Flashman, E, et al.
Published: (2010)

Hypoxia-inducible factor prolyl hydroxylase 2 has a high affinity for ferrous iron and 2-oxoglutarate.
by: McNeill, L, et al.
Published: (2005)

Studies on spiro[4.5]decanone prolyl hydroxylase domain inhibitors
by: Holt-Martyn, J, et al.
Published: (2019)

Structural and mechanistic studies on prolyl hydroxylases
by: Chowdhury, R
Published: (2008)

Small-molecules that covalently react with a human prolyl hydroxylase – towards activity modulation and substrate capture
by: Bush, J, et al.
Published: (2018)

Kinetic rationale for selectivity toward N- and C-terminal oxygen-dependent degradation domain substrates mediated by a loop region of hypoxia-inducible factor prolyl hydroxylases.
by: Flashman, E, et al.
Published: (2008)

A small-molecule probe for monitoring binding to prolyl hydroxylase domain 2 by fluorescence polarisation
by: Li, Z, et al.
Published: (2020)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
by: Chowdhury, R, et al.
Published: (2016)

Cellular oxygen sensing: Crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2).
by: McDonough, M, et al.
Published: (2006)

Structural basis for binding of the renal carcinoma target hypoxia-inducible factor 2α to prolyl hydroxylase domain 2
by: Figg, WD, et al.
Published: (2023)

Dual-action inhibitors of HIF prolyl hydroxylases that induce binding of a second iron ion.
by: Yeoh, K, et al.
Published: (2013)

Studies on the substrate selectivity of the hypoxia-inducible factor prolyl hydroxylase 2 catalytic domain
by: Abboud, M, et al.
Published: (2018)

The use of dioxygen by HIF prolyl hydroxylase (PHD1).
by: McNeill, L, et al.
Published: (2002)

Inhibition of a viral prolyl hydroxylase
by: Langley, G, et al.
Published: (2019)

Prolyl hydroxylases and therapeutics.
by: Smith, T, et al.
Published: (2010)

Mechanistic studies on human prolyl hydroxylase domain 2
by: Fiorini, G
Published: (2024)

Evidence for the slow reaction of hypoxia-inducible factor prolyl hydroxylase 2 with oxygen.
by: Flashman, E, et al.
Published: (2010)

Evidence for the slow reaction of hypoxia-inducible factor prolyl hydroxylase 2 with oxygen.
by: Flashman, E, et al.
Published: (2010)

Regulation of HIF: prolyl hydroxylases.
by: Stolze, I, et al.
Published: (2006)

Substrate selectivity of prolyl hydroxylases
by: McDonough, M
Published: (2018)

IC-MS ESI development
by: Walsby-Tickle, J
Published: (2020)

Use of cyclic peptides to induce crystallization – case study with prolyl hydroxylase domain 2
by: Chowdhury, R, et al.
Published: (2020)

Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase, and is sensitive to off target inhibition by prolyl hydroxylase domain inhibitors that stabilise Hypoxia Inducible Factor
by: Kiriakidis, S, et al.
Published: (2017)

Structure–activity relationship and crystallographic studies on 4-hydroxypyrimidine HIF prolyl hydroxylase domain inhibitors
by: Holt-Martyn, JP, et al.
Published: (2019)

Exploring the substrate selectivity of oxygen sensing prolyl hydroxylases
by: Lippl, K, et al.
Published: (2015)

Molecular and Cellular Mechanisms of HIF Prolyl Hydroxylase inhibitors in Clinical Trials
by: Yeh, TL, et al.
Published: (2017)

Tissue expression and functional insights into HIF prolyl hydroxylase domain enzymes
by: Wijeyekoon, JB
Published: (2013)

2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase.
by: Mole, D, et al.
Published: (2003)

Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases.
by: Schlemminger, I, et al.
Published: (2003)

Novel and selective small molecule inhibitors and activators for the prolyl hydroxylase domain enzyme
by: Holt-Martyn, J
Published: (2018)